Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Cipla
QuintilesIMS
Colorcon
Express Scripts
McKesson
Daiichi Sankyo
Cantor Fitzgerald
Harvard Business School

Generated: June 22, 2018

DrugPatentWatch Database Preview

HYDASE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Hydase, and when can generic versions of Hydase launch?

Hydase is a drug marketed by Akorn Inc and is included in one NDA.

The generic ingredient in HYDASE is hyaluronidase. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the hyaluronidase profile page.
Summary for HYDASE
US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: 1
Formulation / Manufacturing:see details
DailyMed Link:HYDASE at DailyMed
Drug patent expirations by year for HYDASE
Pharmacology for HYDASE
Ingredient-typeGlycoside Hydrolases
Drug ClassEndoglycosidase

US Patents and Regulatory Information for HYDASE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn Inc HYDASE hyaluronidase INJECTABLE;INJECTION 021716-001 Oct 25, 2005 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Fish and Richardson
Healthtrust
Johnson and Johnson
Chubb
Mallinckrodt
US Army
Queensland Health
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.